DIMENSIONAL FUND ADVISORS LP - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 104 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$487,000
-32.1%
112,646
-37.3%
0.00%
Q2 2019$717,000
-29.8%
179,639
-5.7%
0.00%
Q1 2019$1,021,000
+3.8%
190,401
-0.7%
0.00%
Q4 2018$984,000
-47.1%
191,7790.0%0.00%
-100.0%
Q3 2018$1,860,000
+145.7%
191,779
+553.1%
0.00%
Q2 2015$757,000
-18.5%
29,363
-1.2%
0.00%
-100.0%
Q1 2015$929,000
-35.8%
29,729
-20.8%
0.00%0.0%
Q4 2014$1,447,00037,5450.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders